Cholesterol homeostasis in two commonly used human prostate cancer cell-lines, LNCaP and PC-3. 2009

James Robert Krycer, and Ika Kristiana, and Andrew John Brown
School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia.

BACKGROUND Recently, there has been renewed interest in the link between cholesterol and prostate cancer. It has been previously reported that in vitro, prostate cancer cells lack sterol-mediated feedback regulation of the major transcription factor in cholesterol homeostasis, sterol-regulatory element binding protein 2 (SREBP-2). This could explain the accumulation of cholesterol observed in clinical prostate cancers. Consequently, perturbed feedback regulation to increased sterol levels has become a pervasive concept in the prostate cancer setting. Here, we aimed to explore this in greater depth. RESULTS After altering the cellular cholesterol status in LNCaP and PC-3 prostate cancer cells, we examined SREBP-2 processing, downstream effects on promoter activity and expression of SREBP-2 target genes, and functional activity (low-density lipoprotein uptake, cholesterol synthesis). In doing so, we observed that LNCaP and PC-3 cells were sensitive to increased sterol levels. In contrast, lowering cholesterol levels via statin treatment generated a greater response in LNCaP cells than PC-3 cells. This highlighted an important difference between these cell-lines: basal SREBP-2 activity appeared to be higher in PC-3 cells, reducing sensitivity to decreased cholesterol levels. CONCLUSIONS Thus, prostate cancer cells are sensitive to changing sterol levels in vitro, but the extent of this regulation differs between prostate cancer cell-lines. These results shed new light on the regulation of cholesterol metabolism in two commonly used prostate cancer cell-lines, and emphasize the importance of establishing whether or not cholesterol homeostasis is perturbed in prostate cancer in vivo.

UI MeSH Term Description Entries
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D051782 Sterol Regulatory Element Binding Protein 2 A sterol regulatory element binding protein that regulates GENES involved in CHOLESTEROL synthesis and uptake. SRE-2 Binding Protein,SREBP2 Protein,Sterol-Regulatory Element-Binding Protein 2,SRE 2 Binding Protein
D052138 Genes, Neoplasm Genes whose abnormal expression, or MUTATION are associated with the development, growth, or progression of NEOPLASMS. Cancer Genes,Neoplasm Genes,Cancer Gene,Gene, Cancer,Gene, Neoplasm,Genes, Cancer,Neoplasm Gene

Related Publications

James Robert Krycer, and Ika Kristiana, and Andrew John Brown
September 2018, Gene,
James Robert Krycer, and Ika Kristiana, and Andrew John Brown
January 1997, Anticancer research,
James Robert Krycer, and Ika Kristiana, and Andrew John Brown
May 1997, Biochemical and biophysical research communications,
James Robert Krycer, and Ika Kristiana, and Andrew John Brown
August 1998, Cancer research,
James Robert Krycer, and Ika Kristiana, and Andrew John Brown
June 2002, International journal of cancer,
James Robert Krycer, and Ika Kristiana, and Andrew John Brown
January 2013, PloS one,
James Robert Krycer, and Ika Kristiana, and Andrew John Brown
July 2000, Urologic oncology,
James Robert Krycer, and Ika Kristiana, and Andrew John Brown
April 1998, The Prostate,
James Robert Krycer, and Ika Kristiana, and Andrew John Brown
February 2001, Urology,
James Robert Krycer, and Ika Kristiana, and Andrew John Brown
January 1999, Histology and histopathology,
Copied contents to your clipboard!